Coral Laboratories Ltd share price logo

Coral Laboratories Ltd Share Price (524506)

₹472.051.39%

as on

| Source : BSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Coral Laboratories Ltd Stock Performance

as on August 22, 2025 at 4:01 PM IST

  • Day's Low

    Day's High

    ₹470
    ₹481.5
    downward going graph

    0.43%

    Downside

    2.00%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹470
    ₹999
    downward going graph

    0.43%

    Downside

    111.63%

    Upside

    downward going graph
Previous Close₹478.70
Open₹478.70
Volume961.00
Upper Circuit₹574.40
Lower Circuit₹383.00
Day's Low470
Day's High481.5
52 Week Low470
52 Week High999
1 Month Return-16.2 %
3 Month Return-35.25 %
1 Year Return-47.22 %
3 Year Return+ 92.56 %
5 Year Return+ 59.2 %

Coral Laboratories Ltd Stock Fundamentals & Key Indicators

Check Coral Laboratories Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹170.90 Cr

Return on Equity (ROE)

9.5

PE Ratio (TTM)

0

Return on capital employed (ROCE)

12.26

Beta (LTM)

0.9

P/B Ratio

0.75

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

-70.91

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Coral Laboratories Ltd Stock's Interest Amongst Investors

36%

Period Aug 23, 2025 to Jul 24, 2025. Change in 30 Days vs previous period

Search interest for Coral Laboratories Ltd Stock has increased by 36% in the last 30 days, reflecting an upward trend in search activity.

Coral Laboratories Ltd Financial Results

Get the annual and quarterly financial summary of Coral Laboratories Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26
Revenue

(in ₹ Cr)

32 (0%)32 (2%)23 (29%)28 (22%)19 (33%)
Net Income

(in ₹ Cr)

9 (0%)6 (28%)6 (4%)3 (54%)3 (10%)
Net Profit Margin27.80% (0%)19.80% (29%)26.71% (35%)10.06% (62%)13.60% (35%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

168 (0%)190 (13%)174 (8%)206 (18%)
Total Liabilities

(in ₹ Cr)

31 (0%)34 (10%)20 (42%)28 (44%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

-4 (0%)1 (124%)6 (554%)13 (108%)-5 (143%)

Coral Laboratories Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Coral Laboratories Ltd.

  • Coral Laboratories Ltd Earnings Results

    Coral Laboratories Ltd’s net profit fell -70.91% since last year same period to ₹2.56Cr in the Q1 2025-2026. On a quarterly growth basis, Coral Laboratories Ltd has generated -9.54% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Coral Laboratories Ltd Dividends July,2024

    In the quarter ending June 2024, Coral Laboratories Ltd has declared dividend of ₹2.00 per share on 12 Jul 2024 - translating a dividend yield of 0.42%.

    Read More about Dividends

Coral Laboratories Ltd Stock Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Coral Laboratories Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
71.51%
0.00
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
28.49%
0.00
Others
0%
0.00

Coral Laboratories Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Coral Laboratories Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA170.9011.84%0.001583
NA144.7017.83%0.847339
NA509.1222.09%0.00NANA
NA732.0831.15%0.514211,280
NA6.03-7.89%0.00-6NA

Coral Laboratories Ltd News & Key Events

Latest news and events in one place to help you make informed investing decisions in Coral Laboratories Ltd.

  • Coral Labs Reports Decline in Sales and Profit - 10 Jun, 2025

    Coral Laboratories reported a 2.6% decline in net sales to Rs 28.13 crore for March 2025, with net profit down 51.14% to Rs 2.83 crore. EBITDA also fell by 38.01%. The stock closed at Rs 589.50, reflecting a -26.45% return over the last 6 months.

Insights on Coral Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 71.51% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 22.7% return, outperforming this stock by 70.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 138.9% return, outperforming this stock by 46.3%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 28.49% of holdings in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, Coral Labs. stock has moved down by -16.2%

About Coral Laboratories Ltd

Coral Laboratories Limited (CLL), based in India and headed by Kishor R Mehta as Executive Director, produces various pharmaceutical formulations such as tablets and capsules. CLL went into public issue in March 1994 at a total cost of Rs.2.5 crores and has since successfully expanded its activities into the sophisticated FFS form fill and seal technology for injections, with all required machinery to be imported. To further expand, the company has also diverted into housing construction and financial services in order to create a new company, Coral India Finance and Housing. Additionally, CLL has also received the prestigious ISO9002 Certification, in the year 19992000. Promoted by Navin B Doshi of the DWD group, CLL is expanding its avenues to ensure that the highest quality pharmaceutical formulations are provided to its customers.

Revenue: ₹18.82Cr as on June 2025 (Q1 FY26)
Net Profit: ₹2.56Cr as on June 2025 (Q1 FY26)
OrganisationCoral Laboratories Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Coral Laboratories Ltd share price today?

Coral Laboratories Ltd share price today stands at ₹472.05, Open: ₹478.7, Previous Close: ₹478.7, High: ₹481.5, Low: ₹470, 52 Week High: ₹999, 52 Week Low: ₹470 as on .

How to buy Coral Laboratories Ltd shares ?

To buy Coral Laboratories Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 524506 or Coral Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Coral Laboratories Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is today's traded volume of Coral Laboratories Ltd?

Today's traded volume of Coral Laboratories Ltd is 961.00. Which means that 961.00 shares of Coral Laboratories Ltd were bought and sold on the stock market during today's trading session.

What is Coral Laboratories Ltd's market cap today?

Today's market capitalisation of Coral Laboratories Ltd is ₹170.90 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Coral Laboratories Ltd?

Coral Laboratories Ltd’s 52 week high is ₹999 and 52 week low is ₹470. The current share price of Coral Laboratories Ltd is ₹472.05, which is -52.75% down from its 52 week high and 0.44% up from its 52 week low.